Focus: Molecular Matrix is a biotechnology company specializing in bone graft substitutes for musculoskeletal applications. Founded in 2011 and based in Rancho Cordova, CA, the company operates as a focused biotech player in the orthopedic biomaterials space.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Molecular Matrix presents a high-risk, early-stage opportunity suitable only for candidates seeking deep technical roles in biomaterials with high tolerance for uncertainty and limited growth infrastructure.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Molecular Matrix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Molecular Matrix's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo